【分享】FDA的三个指导原则翻译
Biosimilarity | Guidance for Industry on Biosimilars: Q & As Regarding Implementation of the BPCI Act of 2009 | Draft GuidanceUpdated for 508 on 3/22/12. | 02/09/12 |
Biosimilarity | Scientific Considerations in Demonstrating Biosimilarity to a Reference Product (PDF - 576KB) | Draft Guidance | 02/09/12 |
Biosimilarity | Quality Considerations in Demonstrating Biosimilarity to a Reference Protein Product (PDF - 432KB) | Draft Guidance | 02/09/12 |
最后编辑于 2022-10-09 · 浏览 5636